Background: In patients with chronic heart failure, physical evaluation and clinical judgmentmay be inadequate for prognostic stratification. Hypothesis: Information obtained with simple bedside tests would be helpful in patient management. Methods: We report on 142 outpatients with systolic heart failure seen at our heart failure unit from 2007 to 2010 (ages 69.4 ± 8.9 years; ejection fraction [EF] 30.6 ± 6.1%; 43% with implanted defibrillators and/or resynchronization devices). At their first visit, we assessed levels of brain natriuretic peptide (BNP) (pg/mL), evaluated transthoracic conductance (TFC) (1/k ) by transthoracic bioimpedance, and performed echocardiography. Results: Four-yearmortality was 21.2%. Atmultivariate analysis, surviving and deceased subjects did not differ regarding New York Heart Association, age, gender, heart failure etiology, or EF at index visit. Patients who died had higher BNP and TFC (BNP = 884 ± 119 pg/mL vs 334 ± 110 pg/mL; TFC = 50 ± 8/k vs 37 ± 7/k , both P < 0.001]. Patients with BNP < 450 pg/mL and TFC < 40/k had a 2.1% 4-year mortality, compared to 46.5% mortality of patients having BNP ≥ 450 pg/mL and TFC ≥ 40/k . BNP ≥ 450 pg/mL and TFC ≥ 40/k showed high sensitivity (91%) and specificity (88%)in identifying patients who died at follow-up. Conclusions: The combined use of BNP and impedance cardiography during the first assessment of a patient in a heart failure unit identified those carrying a worse medium-term prognosis. This approach could help the subsequent management of patients, allowing better clinical and therapeutic strategies.

Malfatto, G., Corticelli, A., Villani, A., Giglio, A., DELLA ROSA, F., Branzi, G., et al. (2013). Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure. CLINICAL CARDIOLOGY, 36, 103-109 [10.1002/clc.22086].

Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure.

CORTICELLI, ALFREDO;GIGLIO, ALESSIA MAFALDA;DELLA ROSA, FRANCESCO;PARATI, GIANFRANCO
2013

Abstract

Background: In patients with chronic heart failure, physical evaluation and clinical judgmentmay be inadequate for prognostic stratification. Hypothesis: Information obtained with simple bedside tests would be helpful in patient management. Methods: We report on 142 outpatients with systolic heart failure seen at our heart failure unit from 2007 to 2010 (ages 69.4 ± 8.9 years; ejection fraction [EF] 30.6 ± 6.1%; 43% with implanted defibrillators and/or resynchronization devices). At their first visit, we assessed levels of brain natriuretic peptide (BNP) (pg/mL), evaluated transthoracic conductance (TFC) (1/k ) by transthoracic bioimpedance, and performed echocardiography. Results: Four-yearmortality was 21.2%. Atmultivariate analysis, surviving and deceased subjects did not differ regarding New York Heart Association, age, gender, heart failure etiology, or EF at index visit. Patients who died had higher BNP and TFC (BNP = 884 ± 119 pg/mL vs 334 ± 110 pg/mL; TFC = 50 ± 8/k vs 37 ± 7/k , both P < 0.001]. Patients with BNP < 450 pg/mL and TFC < 40/k had a 2.1% 4-year mortality, compared to 46.5% mortality of patients having BNP ≥ 450 pg/mL and TFC ≥ 40/k . BNP ≥ 450 pg/mL and TFC ≥ 40/k showed high sensitivity (91%) and specificity (88%)in identifying patients who died at follow-up. Conclusions: The combined use of BNP and impedance cardiography during the first assessment of a patient in a heart failure unit identified those carrying a worse medium-term prognosis. This approach could help the subsequent management of patients, allowing better clinical and therapeutic strategies.
Articolo in rivista - Articolo scientifico
Brain natriuretic peptide,chronic systolic heart failure
English
2013
36
103
109
reserved
Malfatto, G., Corticelli, A., Villani, A., Giglio, A., DELLA ROSA, F., Branzi, G., et al. (2013). Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure. CLINICAL CARDIOLOGY, 36, 103-109 [10.1002/clc.22086].
File in questo prodotto:
File Dimensione Formato  
Transthoracic bioimpedance- Clin Cardiol 2013.pdf

Solo gestori archivio

Dimensione 172.88 kB
Formato Adobe PDF
172.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/42008
Citazioni
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 15
Social impact